Tarragona, Spain

Yolanda Diaz

This inventor holds 1 USPTO granted patent. Top assignee: Lanxess Deutschland Gmbh. Active years: 2007.


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yolanda Diaz - Innovator in Chiral Diphosphorus Compounds

Introduction

Yolanda Diaz is a prominent inventor based in Tarragona, Spain. She has made significant contributions to the field of chemistry, particularly in the development of chiral diphosphorus compounds and their transition metal complexes. Her work is essential for advancing asymmetric syntheses, which are crucial in various chemical applications.

Latest Patents

Yolanda Diaz holds a patent for "Chiral diphosphorus compounds and their transition metal complexes." This invention relates to the preparation of chiral diphosphorus compounds and their transition metal complexes, along with their applications in asymmetric syntheses. Her innovative approach has the potential to enhance the efficiency and effectiveness of chemical reactions.

Career Highlights

Yolanda is currently employed at Lanxess Deutschland GmbH, where she continues to push the boundaries of chemical research. Her expertise in chiral compounds has positioned her as a valuable asset in her field. With a focus on practical applications, she aims to contribute to advancements in various industries.

Collaborations

Yolanda has collaborated with notable colleagues, including Benjamin Meseguer and Hans-Christian Militzer. These partnerships have fostered a dynamic research environment, allowing for the exchange of ideas and expertise.

Conclusion

Yolanda Diaz is a trailblazer in the field of chiral chemistry, with a patent that showcases her innovative spirit. Her work at Lanxess Deutschland GmbH and collaborations with esteemed colleagues highlight her commitment to advancing scientific knowledge. Through her contributions, she continues to inspire future generations of inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…